| P50 | author | Chuanju Liu | Q56541788 |
| P2093 | author name string | Qingyun Tian | |
| | William Stohl | |
| | Jennifer Johnson | |
| | Jinlong Jian | |
| | Karen Yeter | |
| | Lorenz Thurner | |
| | Natalie Fadle | |
| | Rebekah Neal | |
| | Rosy Rajbhandary | |
| P2860 | cites work | A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate | Q28295474 |
| | Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 |
| | Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin | Q30482362 |
| | Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice | Q33615151 |
| | Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 |
| | Progranulin antibodies in autoimmune diseases | Q34476012 |
| | Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial | Q34530459 |
| | Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont | Q34547981 |
| | The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice | Q35014661 |
| | Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis | Q35163334 |
| | Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis | Q35203303 |
| | Progranulin: a growth factor, a novel TNFR ligand and a drug target | Q35601050 |
| | Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis | Q35962863 |
| | Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity | Q36907736 |
| | Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis | Q37690364 |
| | The molecular basis for development of proinflammatory autoantibodies to progranulin | Q38871393 |
| | The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling | Q39142580 |
| | Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling | Q39918340 |
| | Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair | Q40677795 |
| | Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. | Q41933726 |
| | PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner | Q43000967 |
| | 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 |
| | A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis | Q73235899 |
| | Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response | Q81355286 |
| | Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis | Q87825112 |
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 507-516 | |
| P577 | publication date | 2016-11-09 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study | |
| P478 | volume | 36 | |